Toren A - Search Results

1

NCAM1/FGF module serves as a putative pleuropulmonary blastoma therapeutic target.

Shukrun R, Golan H, Caspi R, Pode-Shakked N, Pleniceanu O, Vax E, Bar-Lev DD, Pri-Chen S, Jacob-Hirsch J, Schiby G, Harari-Steinberg O, Mark-Danieli M, Dekel B, Toren A. Shukrun R, et al. Among authors: toren a. Oncogenesis. 2019 Sep 2;8(9):48. doi: 10.1038/s41389-019-0156-9. Oncogenesis. 2019. PMID: 31477684 Free PMC article.

2

Helicobacter pylori-associated gastric lymphoma in a girl.

Sharon N, Kenet G, Toren A, Mandel M, Neumann Y, Kaplinsky C, Schiby G, Rechavi G. Sharon N, et al. Among authors: toren a. Pediatr Hematol Oncol. 1997 Mar-Apr;14(2):177-80. doi: 10.3109/08880019709030904. Pediatr Hematol Oncol. 1997. PMID: 9089746

3

Instability of dinucleotide repeats in Hodgkin's disease.

Mark Z, Toren A, Amariglio N, Schiby G, Brok-Simoni F, Rechavi G. Mark Z, et al. Among authors: toren a. Am J Hematol. 1998 Feb;57(2):148-52. doi: 10.1002/(sici)1096-8652(199802)57:2<148::aid-ajh10>3.0.co;2-8. Am J Hematol. 1998. PMID: 9462548 Free article.

4

Stem-cell transplantation for primary immunodeficiencies.

Bielorai B, Golan H, Rechavi G, Toren A. Bielorai B, et al. Among authors: toren a. Isr Med Assoc J. 2002 Aug;4(8):648-52. Isr Med Assoc J. 2002. PMID: 12183876 Free article. Review.

5

Combined analysis of morphology and fluorescence in situ hybridization in follow-up of minimal residual disease in a child with Philadelphia-positive acute lymphoblastic leukemia.

Bielorai B, Golan H, Trakhtenbrot L, Reichart M, Toren A, Daniely M, Zilberstein Y, Amariglio N, Rechavi G, Kaplinsky C. Bielorai B, et al. Among authors: toren a. Cancer Genet Cytogenet. 2002 Oct 1;138(1):64-8. doi: 10.1016/s0165-4608(02)00578-2. Cancer Genet Cytogenet. 2002. PMID: 12419587

6

Detection of RAG mutations and prenatal diagnosis in families presenting with either T-B- severe combined immunodeficiency or Omenn's syndrome.

Tabori U, Mark Z, Amariglio N, Etzioni A, Golan H, Biloray B, Toren A, Rechavi G, Dalal I. Tabori U, et al. Among authors: toren a. Clin Genet. 2004 Apr;65(4):322-6. doi: 10.1111/j.1399-0004.2004.00227.x. Clin Genet. 2004. PMID: 15025726

7

CD133-positive hematopoietic stem cell "stemness" genes contain many genes mutated or abnormally expressed in leukemia.

Toren A, Bielorai B, Jacob-Hirsch J, Fisher T, Kreiser D, Moran O, Zeligson S, Givol D, Yitzhaky A, Itskovitz-Eldor J, Kventsel I, Rosenthal E, Amariglio N, Rechavi G. Toren A, et al. Stem Cells. 2005 Sep;23(8):1142-53. doi: 10.1634/stemcells.2004-0317. Stem Cells. 2005. PMID: 16140871

8

Mechanisms operative in the antitumor activity of temozolomide in glioblastoma multiforme.

Fisher T, Galanti G, Lavie G, Jacob-Hirsch J, Kventsel I, Zeligson S, Winkler R, Simon AJ, Amariglio N, Rechavi G, Toren A. Fisher T, et al. Among authors: toren a. Cancer J. 2007 Sep-Oct;13(5):335-44. doi: 10.1097/PPO.0b013e318157053f. Cancer J. 2007. PMID: 17921733

9

Integration of a palliative and terminal care center into a comprehensive pediatric oncology department.

Golan H, Bielorai B, Grebler D, Izraeli S, Rechavi G, Toren A. Golan H, et al. Among authors: toren a. Pediatr Blood Cancer. 2008 May;50(5):949-55. doi: 10.1002/pbc.21476. Pediatr Blood Cancer. 2008. PMID: 18240176

10

Therapy-related acute myeloid leukemia with t(2;11)(q37;q23) after treatment for osteosarcoma.

Bielorai B, Meyer C, Trakhtenbrot L, Golan H, Rozner E, Amariglio N, Izraeli S, Marschalek R, Toren A. Bielorai B, et al. Among authors: toren a. Cancer Genet Cytogenet. 2010 Dec;203(2):288-91. doi: 10.1016/j.cancergencyto.2010.08.002. Cancer Genet Cytogenet. 2010. PMID: 21156246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

241 results

Search Page